0001735936-24-000001.txt : 20240606 0001735936-24-000001.hdr.sgml : 20240606 20240605182428 ACCESSION NUMBER: 0001735936-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240605 EFFECTIVENESS DATE: 20240606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Osteal Therapeutics, Inc. CENTRAL INDEX KEY: 0001735936 ORGANIZATION NAME: IRS NUMBER: 900939060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515264 FILM NUMBER: 241023322 BUSINESS ADDRESS: STREET 1: 105 AVENIDA DE LA ESTRELLA STREET 2: SUITE 3 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 650-691-5030 MAIL ADDRESS: STREET 1: 105 AVENIDA DE LA ESTRELLA STREET 2: SUITE 3 CITY: SAN CLEMENTE STATE: CA ZIP: 92672 FORMER COMPANY: FORMER CONFORMED NAME: Joint Purification Systems, Inc. DATE OF NAME CHANGE: 20180328 D 1 primary_doc.xml X0708 D LIVE 0001735936 Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 (469) 809-2630 DELAWARE Joint Purification Systems LLC Joint Purification Systems, Inc. Corporation true David Thompson c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Executive Officer Director Rushu Luo c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Judson Cooper c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Biren Mehta c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director David Cash c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Brian de Beaubien c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Douglas Kohrs c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Martin Sands c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Sonal Patel c/o Osteal Therapeutics, Inc. 835 Lyndon B. Johnson Fwy Ste 635 Dallas TX TEXAS 75244 Director Pharmaceuticals Decline to Disclose 06b false 2024-05-22 false true false 0 49999999 49999926 73 false 16 0 0 0 false Osteal Therapeutics, Inc. /s/ David Thompson David Thompson CEO 2024-06-05